Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
The latest update is out from Vitasora Health ( (AU:VHL) ).
Vitasora Health Limited has announced the issuance of 118,633,332 fully paid ordinary shares, raising AU$3.559 million from a cornerstone investor, with an additional AU$3.191 million expected by December 22, 2025. This financial move is part of their ongoing efforts to strengthen their market position and expand their innovative healthcare solutions, which are designed to improve patient care and reduce costs. The issuance was conducted without disclosure under specific provisions of the Corporations Act, and the company has complied with all necessary regulations, ensuring transparency and compliance with investor information requirements.
More about Vitasora Health
Vitasora Health Limited is a pioneering company in the digital Connected Care industry, primarily focused on the U.S. healthcare market. They offer remote patient monitoring (RPM) and chronic care management (CCM) services, utilizing cutting-edge technologies and expert clinical teams to improve patient outcomes and reduce costs. Their innovative solutions, including the FDA-approved wheezo® device for respiratory disorders, are integrated into existing healthcare systems to enhance efficiency and care quality.
Average Trading Volume: 2,358,184
Technical Sentiment Signal: Sell
Current Market Cap: A$45.23M
For a thorough assessment of VHL stock, go to TipRanks’ Stock Analysis page.